كانيفيرم حبوب ديدان الشريطية للقطط والكلاب, 0.7 جرام، تباع بالحبة

Pharmaceutical form

Tablet. Oval, yellowish biconvex tablets with small spots and a central dividing line on both sides.

Composition

1 tablet weighing 0.7 g contains:

Active substances:

Fenbendazolum                                              150 mg

Pyranteli embonas                                          144 mg

Praziquantelum                                               50 mg

Indication

Diseases caused by nematodes and tapeworms of dogs, cats, feline and canine beasts elem. (Toxocara canis, Toxocara cati, Toxascaris leonina, Uncinaria stenocephala, Ancylostoma caninum, Trichuris vuplis, Echinoccus granulosus, Echinocccus multilocularis, Dipylidium caninum, Taenia spp., Multiceps multiceps, Mesocestoides spp.).

Target animals

Dogs, cats. Feline and canine beasts.

Dosage and application

Single oral administration.

Puppies, small breeds of dogs and cats:

- 1/2 tablet 0.7 g per 2 - 5 kg b.w. 

Medium breeds of dogs:

- 1 tablet 0.7 g per 5 - 10 kg b.w.

Large breeds of dogs and large beasts:

- 1 tablet 0.7 g per each started 10 kg b.w.

The tablets can be given alone or wrapped in a piece of food. Do not administer simultaneously with the dairy food.
 

For the beasts (feline, canine) in zoos, circuses, etc., it is recommended to mix the crushed tablets according to the weight of the beast into a meatball and distribute them in the paddock according to the number of animals before the morning feeding.

It is recommended to deworm the pups from the 3rd to 12th week of age as a single dose, in the interval of 3 weeks, and then regularly every 3 months.

Use during pregnancy, lactation or laying

In pregnant bitches, the dosage should be followed exactly.

Storage

Do not store above 25°C.

Store in a dry place.

Protect from light.

Withdrawal period

Not intended for food-producing animals.

Contraindications

Ocular cysticercosis and spinal neurocysticercosis.

Liver damage.

Do not use in case of hypersensitivity to the active substances or to any of the excipients.

Interaction with other medicinal product and other forms of interaction

Do not administer at the same time with piperazine-based medicinal products and/or with other antiparasitic agents.

Shelf life

Shelf life of the medicinal product for veterinary use in the intact pack: 2 years